TPE PVA TePla AG
PVA TePla AG, together with its subsidiaries, offers systems and solutions to produce components for energy storage systems, photovoltaic modules, and wind turbines worldwide. The company operates through Semiconductor Systems and Industrial Systems segments. The Semiconductor Systems segment provides solutions and systems for the semiconductor industry, including crystal growing systems, metrology systems for quality control, and plasma systems for removing surface contamination from wafers. The Industrial Systems segment offers solutions and systems for the production and refinement of materials; surface treatment; and monitoring production processes configured primarily for the needs and requirements of other industrial areas, such as the medical, electrical, and tool industries. The solutions are used in semiconductor technology, mobility, aerospace, automotive industries, materials science, and the renewable energy industry. The company has its operations in Germany, France, Italy, Switzerland, the United States, China, Taiwan, Korea, and Singapore. It also provides services comprising product and process development, soldering, welding, and heat treatment. The company was founded in 1977 and is headquartered in Wettenberg, Germany.…
Industry Peers
Semiconductor Equipment & MaterialsKey Statistics
About PVA TePla (ETR: TPE)
›
PVA TePla (ETR: TPE) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Semiconductor Equipment & Materials industry, part of the Technology sector, and reports about 1,069 employees.
The shares were at 27.24 EUR on 19 November 2026, up 33.9% over 52 weeks. Its 52-week range is 19.67 EUR to 46.74 EUR: the price is 41.7% below the high and 38.5% above the low.
Its market capitalisation is 556.31M EUR.
PVA TePla reports return on equity of 5.3%, an operating margin of 2.3% and revenue up 12.3% year over year.
Its debt exceeds its cash by 42.80M EUR, a debt-to-equity ratio of 0.33. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 9 analysts cover the stock, with an average rating of Buy; their mean price target of 42.63 EUR is 56.5% above the current price. The next earnings report is expected on 18 March 2027.